Subject: Peptidomimetics

From: "Pandey, Jaya" <JPandey-.at.-chla.usc.edu>
Date: Wed, 19 Nov 2003 13:38:26 -0800

Dear All,

What criterias one should follow to design the peptide analogues of a
membrane receptor in order to bring the effect of a  toxic ligand down? I
designed few but instead of decreasing the effect somehow they are
potentiating the effect of the toxin!!

If any one has any advice or experience in this please help!

Thanks,

Jaya